| Nov 18, 2025 |
Nov 20, 2025 |
Dunne Michael W.
|
Director |
Buy |
82.5
|
+6,000
|
2.55%
|
✗
|
$2.2K |
| Aug 8, 2025 |
Aug 12, 2025 |
Dunne Michael W.
|
Director |
Buy |
86.3
|
+15,000
|
6.82%
|
✗
|
$10.9K |
| Jul 1, 2025 |
Jul 3, 2025 |
Coyne Christine
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 3, 2025 |
Coyne Christine
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 18, 2025 |
Whalen Joseph John
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 13, 2025 |
Jan 23, 2025 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 6, 2024 |
Aug 12, 2024 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 6, 2024 |
Aug 12, 2024 |
Fishman Corey N.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 6, 2024 |
Aug 12, 2024 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 22, 2023 |
Dec 27, 2023 |
Dunne Michael W.
|
Director |
Buy |
91.3
|
+25,000
|
28.17%
|
✗
|
$35K |
| Dec 18, 2023 |
Dec 19, 2023 |
Dunne Michael W.
|
Director |
Buy |
91.3
|
+10,000
|
12.70%
|
✗
|
$18.4K |
| Dec 1, 2023 |
Dec 4, 2023 |
Puttagunta Sailaja
|
Chief Medical Officer |
Sell |
90.0
|
+5,400
|
108.67%
|
✗
|
$6.2K |
| Nov 22, 2023 |
Nov 27, 2023 |
Dunne Michael W.
|
Director |
Buy |
91.3
|
+20,000
|
34.04%
|
✗
|
$40.7K |
| Nov 20, 2023 |
Nov 20, 2023 |
Fishman Corey N.
|
CEO |
Buy |
91.3
|
+10,000
|
22.50%
|
✗
|
$15.9K |
| Oct 1, 2023 |
Oct 2, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2023 |
Oct 2, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2023 |
Jul 3, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2023 |
Jul 3, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 15, 2023 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 15, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 15, 2023 |
Chin Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2023 |
Jun 5, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2023 |
Apr 3, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2023 |
Apr 3, 2023 |
Matthews Judith M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2023 |
Apr 3, 2023 |
Puttagunta Sailaja
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2023 |
Apr 3, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 31, 2023 |
Apr 3, 2023 |
Fishman Corey N.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2023 |
Mar 14, 2023 |
Matthews Judith M.
|
CFO |
Sell |
90.0
|
+3,783
|
86.93%
|
✗
|
$2.8K |
| Mar 11, 2023 |
Mar 14, 2023 |
Fishman Corey N.
|
CEO |
Sell |
90.0
|
+8,650
|
24.16%
|
✗
|
$5.5K |
|
Feb 27, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2023 |
Jan 4, 2023 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 1, 2023 |
Jan 4, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2022 |
Dec 28, 2022 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2022 |
Dec 28, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2022 |
Dec 28, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2022 |
Dec 5, 2022 |
Puttagunta Sailaja
|
Chief Medical Officer |
Sell |
90.0
|
+4,969
|
100.00%
|
✗
|
$4.4K |
| Sep 25, 2022 |
Sep 28, 2022 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 25, 2022 |
Sep 27, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 25, 2022 |
Sep 27, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 16, 2022 |
Sep 20, 2022 |
Ahrens Brenton Karl
|
Director |
Sell |
22.5
|
-37,246
|
-98.91%
|
✗
|
$67.9K |
| Sep 13, 2022 |
Sep 15, 2022 |
Ahrens Brenton Karl
|
Director |
Sell |
22.5
|
-45,000
|
-54.44%
|
✗
|
$93.8K |
| Sep 8, 2022 |
Sep 12, 2022 |
Ahrens Brenton Karl
|
Director |
Sell |
22.5
|
-33,298
|
-28.72%
|
✗
|
$76.8K |
| Sep 7, 2022 |
Sep 9, 2022 |
Dunne Michael W.
|
Director |
Buy |
91.3
|
+10,000
|
39.10%
|
✗
|
$22.2K |
| Jun 25, 2022 |
Jun 28, 2022 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 25, 2022 |
Jun 28, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 25, 2022 |
Jun 28, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 24, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 24, 2022 |
Chin Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 24, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 24, 2022 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Kelly David George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Chin Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2022 |
Jun 17, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 25, 2022 |
Mar 29, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 25, 2022 |
Mar 29, 2022 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 25, 2022 |
Mar 29, 2022 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2022 |
Mar 22, 2022 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2022 |
Mar 15, 2022 |
Matthews Judith M.
|
CFO |
Sell |
46.3
|
-63,340
|
-49.24%
|
✗
|
$19.6K |
| Mar 11, 2022 |
Mar 15, 2022 |
Matthews Judith M.
|
CFO |
Sell |
91.3
|
+52,868
|
184.65%
|
✗
|
$17.9K |
| Mar 11, 2022 |
Mar 15, 2022 |
Fishman Corey N.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2021 |
Dec 14, 2021 |
Puttagunta Sailaja
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 13, 2021 |
Puttagunta Sailaja
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 25, 2021 |
Jul 27, 2021 |
Dunne Michael W.
|
Director |
Neutral |
90.0
|
+80,000
|
31.21%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Chin Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Kelly David George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Fishman Corey N.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2021 |
Jun 25, 2021 |
Matthews Judith M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 21, 2021 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 25, 2021 |
Mar 29, 2021 |
Dunne Michael W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2021 |
Mar 19, 2021 |
Hecht Beth
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2021 |
Mar 15, 2021 |
Matthews Judith M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2021 |
Mar 15, 2021 |
Fishman Corey N.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 28, 2020 |
Mar 3, 2021 |
Chin Mark
|
Director |
Neutral |
27.5
|
-11,857
|
-100.00%
|
✗
|
- |
| Feb 11, 2021 |
Feb 12, 2021 |
DENNER ALEXANDER J
|
10% Owner |
Sell |
15.0
|
-20,619,949
|
-100.00%
|
✗
|
$50M |
| Feb 4, 2021 |
Feb 8, 2021 |
RA CAPITAL MANAGEMENT, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 25, 2021 |
Jan 27, 2021 |
Fishman Corey N.
|
CEO |
Sell |
95.0
|
+82,055
|
34.20%
|
✗
|
$147.8K |
| Jan 25, 2021 |
Jan 27, 2021 |
Dunne Michael W.
|
Director |
Sell |
95.0
|
+46,857
|
22.37%
|
✗
|
$57.3K |
| Jan 25, 2021 |
Jan 27, 2021 |
Matthews Judith M.
|
CFO |
Sell |
95.0
|
+28,632
|
100.00%
|
✗
|
$58.6K |
|
Dec 2, 2020 |
RA CAPITAL MANAGEMENT, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 23, 2020 |
DENNER ALEXANDER J
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 27, 2020 |
Oct 28, 2020 |
Dunne Michael W.
|
Chief Scientific Officer |
Neutral |
90.0
|
+61,540
|
41.59%
|
✗
|
- |
| Sep 30, 2020 |
Oct 2, 2020 |
Matthews Judith M.
|
CFO |
Sell |
10.0
|
-56,130
|
-100.00%
|
✓
|
$92.1K |
| Jul 1, 2020 |
Jul 6, 2020 |
Heron Patrick J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2020 |
Jul 2, 2020 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2020 |
Jul 2, 2020 |
Chin Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2020 |
Jun 16, 2020 |
Kelly David George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2020 |
Jun 12, 2020 |
Kelly David George
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 1, 2020 |
Jun 3, 2020 |
Sofinnova Venture Partners IX, L.P.
|
10% Owner |
Sell |
20.0
|
-500,000
|
-28.96%
|
✗
|
$812.1K |
| Apr 7, 2020 |
Apr 9, 2020 |
Chin Mark
|
Director |
Neutral |
27.5
|
-1,089,903
|
-99.44%
|
✗
|
- |
| Jan 21, 2020 |
Jan 23, 2020 |
Sofinnova Venture Partners IX, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 21, 2020 |
Jan 23, 2020 |
Frazier Healthcare VII, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 21, 2020 |
Jan 23, 2020 |
CANAAN X L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 21, 2020 |
Jan 23, 2020 |
Ahrens Brenton Karl
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |